Changchun Hi-Tech: Announcement on the signing of strategic cooperation agreements and related transactions by wholly-owned subsidiaries
Changchun Hi-Tech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Changchun Hi-Tech: Review Opinions of the 11th Special Meeting of Independent Directors of the Board of Directors, 1st Meeting in 2025
Changchun Hi-Tech: Announcement of Resolutions of the Eighth Meeting of the 11th Board of Directors
Changchun Hi-Tech: Announcement on the approval and marketing of the cooperative product Children\'s Gold Cough Relief Granules in China
Changchun Hi-Tech: Announcement on the progress of share repurchase
Changchun Hi-Tech: Announcement on the approval of the holding subsidiary\'s application for clinical trials of the freeze-dried Haemophilus influenzae type b conjugate vaccine
Changchun Hi-Tech: Announcement on changing the registered capital and amending the “Articles of Association”
Changchun Hi-Tech: Announcement on increasing the estimated amount of daily related transactions
Changchun Hi-Tech: Announcement on changing the use and cancellation of some repurchased shares
Changchun Hi-Tech: Announcement of Resolutions of the 6th Meeting of the 11th Board of Supervisors
Changchun Hi-Tech: Announcement of Resolutions of the 7th Meeting of the 11th Board of Directors
Changchun Hi-Tech: Audit Opinions at the 2nd Meeting of the 11th Special Meeting of Independent Directors of the Board of Directors in 2024
Changchun Hi-Tech: Announcement on the subsidiary providing a guarantee for its wholly-owned subsidiary
Changchun Hi-Tech: Announcement on Subsidiary GS1-144 Obtaining Implied Approval from the US Food and Drug Administration to Apply for Clinical Trials of New Drugs
Changchun Hi-Tech: Announcement on approval of the holding subsidiary\'s application for clinical trials of the herpes simplex virus mRNA vaccine
Changchun Hi-Tech: Announcement on Obtaining a Medical Device Registration Certificate
Changchun Hi-Tech: An indicative announcement on the change in the holding ratio of bondholders in convertible bonds reached 10% and the shareholders\' shareholding ratio changed by more than 1%
Changchun Hi-Tech: Announcement on the completion of the “Hi-Tech Fixed Transfer” share transfer and delisting
Changchun Hi-Tech: Announcement on approval of the subsidiary GenSci 122 tablet clinical trial application